0001144204-12-057130.txt : 20121022 0001144204-12-057130.hdr.sgml : 20121022 20121022134650 ACCESSION NUMBER: 0001144204-12-057130 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20121022 DATE AS OF CHANGE: 20121022 EFFECTIVENESS DATE: 20121022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synthetic Biologics, Inc. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-185905 FILM NUMBER: 121154319 BUSINESS ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE, STREET 2: SUITE 200 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: (734) 332-7800 MAIL ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE, STREET 2: SUITE 200 CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20061214 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 D 1 primary_doc.xml X0706 D LIVE 0000894158 Synthetic Biologics, Inc. 617 DETROIT STREET, SUITE 100 ANN ARBOR MI MICHIGAN 48104 (734) 332-7800 NEVADA Adeona Pharmaceuticals, Inc. ADEONA PHARMACEUTICALS, INC. PIPEX PHARMACEUTICALS, INC. SHEFFIELD PHARMACEUTICALS INC Corporation true Jeffrey Riley c/o Synthetic Biologics 617 Detroit Avenue, Suite 100 Ann Arbor MI MICHIGAN 48104 Executive Officer Director C. Evan Ballantyne c/o Synthetic Biologics 617 Detroit Avenue, Suite 100 Ann Arbor MI MICHIGAN 48104 Executive Officer Jeffrey J. Kraws c/o Synthetic Biologics 617 Detroit Avenue, Suite 100 Ann Arbor MI MICHIGAN 48104 Director Jeffrey Wolf c/o Synthetic Biologics 617 Detroit Avenue, Suite 100 Ann Arbor MI MICHIGAN 48104 Director Steve H. Kanzer c/o Synthetic Biologics 617 Detroit Avenue, Suite 100 Ann Arbor MI MICHIGAN 48104 Director Scott L. Tarriff c/o Synthetic Biologics 617 Detroit Avenue, Suite 100 Ann Arbor MI MICHIGAN 48104 Director Biotechnology Decline to Disclose 06 false 2012-10-16 false true false 0 7637252 7637252 0 The Company issued 3,552,210 shares of common stock to Intrexon Corp. pursuant to an Exclusive Channel Collaboration Agreement. No cash was received. The amount entered is based solely on the closing price of the Company's stock of $2.15 on 10/16/12. false 1 0 0 0 false Synthetic Biologics, Inc. /s/ Jeffrey Riley Jeffrey Riley President and Chief Executive Officer 2012-10-22